Refine Results
  1. "Lymphoma Disease Management Team"
Formats
  1. Journal Article (1745)
  2. Meeting Abstract (1343)
  3. Book Section (112)
  4. Conference Paper (7)
  5. Book Whole (3)
Groups
  1. Lymphoma Disease Management Team (3210)
  2. Hematologic Oncology, Division of (1491)
  3. Center for Hematologic Malignancies (1477)
  4. Lymphoma Service (1332)
  5. Lymphoma (1144)
  6. Myeloma Disease Management Team (930)

More Groups

People
  1. Andrew Zelenetz (480)
  2. Kenneth Offit (428)
  3. Joachim Yahalom (371)
  4. Craig Moskowitz (340)
  5. Steven Horwitz (317)
  6. Heiko Schoder (266)

More People

Years
  1. 2019 (2)
  2. 2018 (169)
  3. 2017 (251)
  4. 2016 (242)
  5. 2015 (283)
  6. 2014 (273)

More Years

Publications
  1. Blood (534)
  2. Journal of Clinical Oncology (312)
  3. International Journal of Radiation Oncology, Biology, Physics (131)
  4. Modern Pathology (105)
  5. Laboratory Investigation (89)
  6. Journal of Nuclear Medicine (80)

More Publications

Publishers
  1. American Society of Hematology (543)
  2. American Society of Clinical Oncology (322)
  3. Elsevier Inc. (321)
  4. Nature Publishing Group (302)
  5. Springer (169)
  6. American Association for Cancer Research (148)

More Publishers

Results (3210)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Discovery of common and rare genetic risk variants for colorectal cancer
    Journal Article

    Huyghe, J. R.; Bien, S. A.; Harrison, T. A.; Kang, H. M.; Chen, S.; Schmit, S. L.; Conti, D. V.; Qu, C.; Jeon, J.; Edlund, C. K.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Stereotactic breast biopsy efficiency: Does a pre-biopsy grid image help?
    Journal Article

    Mango, V. L.; D'Alessio, D.; Morris, E. A.; Ha, R.; Bernard-Davila, B.; Jochelson, M.
    Clinical Imaging (2019)

    Fulltext@MSK | Save
  • Detecting HER2 alterations by next generation sequencing (NGS) in patients with advanced NSCLC from the United States and China
    Meeting Abstract

    Xu, C.; Zhang, Y.; Liu, D.; Shen, R.; Razavi, P.; Liu, S.; Sun, H.; Offin, M.; Drilon, A.; Rudin, C.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Phase III study of taselisib (GDC-0032) + fulvestrant (FULV) v FULV in patients (pts) with estrogen receptor (ER)-positive, PIK3CA-mutant (MUT), locally advanced or metastatic breast cancer (MBC): Primary analysis from SANDPIPER
    Meeting Abstract

    Baselga, J.; Dent, S. F.; Cortés, J.; Im, Y. H.; Diéras, V.; Harbeck, N.; Krop, I. E.; Verma, S.; Wilson, T. R.; Jin, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Initial results of a dose escalation study of a selective and structurally differentiated PI3K delta inhibitor, ME-401, in relapsed/refractory (R/R) follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
    Meeting Abstract

    Soumerai, J. D.; Pagel, J. M.; Jagadeesh, D.; Salman, H. S.; Kenkre, V. P.; Asch, A. S.; Stathis, A.; Reddy, N. M.; Iasonos, A.; Ghalie, R.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Randomized phase 2 trial of polatuzumab vedotin (pola) with bendamustine and rituximab (BR) in relapsed/refractory (r/r) FL and DLBCL
    Meeting Abstract

    Sehn, L. H.; Kamdar, M.; Herrera, A. F.; McMillan, A.; Flowers, C.; Kim, W. S.; Kim, T. M.; Özcan, M.; Demeter, J.; Hertzberg, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The dual SYK/JAK inhibitor cerdulatinib demonstrates rapid tumor responses in a phase 2 study in patients with relapsed/refractory B- and T-cell non-Hodgkin lymphoma (NHL)
    Meeting Abstract

    Hamlin, P. A.; Cheson, B. D.; Farber, C. M.; Feldman, T.; Fenske, T. S.; Hess, B. T.; Khatcheressian, J. L.; Miller, C. B.; Munoz, J.; Patel, M. R.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The PRIMO study: A phase 2 study of duvelisib efficacy and safety in patients with relapsed or refractory peripheral t-cell lymphoma (PTCL)
    Meeting Abstract

    Horwitz, S. M.; Soto, J.; Youssoufian, H.; Lloyd, D.; Le, N. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Romidepsin activity in T follicular helper(TFH)-phenotype PTCL versus non TFH treated on the same clinical trials
    Meeting Abstract

    Ghione, P.; Ozkaya, N.; Faruque, P.; Mehta-Shah, N.; Lunning, M. A.; Ruan, J.; Galasso, N.; Moskowitz, A. J.; Dogan, A.; Horwitz, S. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save